Hilary Baldwin, MD, and Julie Harper, MD: Updates in the Treatment Landscape of Acne and Rosacea

Drs. Baldwin and Harper provide an update on the evolving management of Acne Vulgaris and Rosacea, reviewing changes in treatment strategies, emerging therapies, and practical approaches to patient care. Their discussion emphasizes evidence-based prescribing, antibiotic stewardship, and innovations that may reshape future treatment paradigms.

Topics Covered

  • Evolving treatment strategies for moderate-to-severe acne
  • Initiating treatment with topical therapies before considering oral antibiotics
  • The importance of antibiotic stewardship in acne management
  • Investigational therapies, including fatty acid synthase inhibitors and acne vaccines aimed at reducing inflammation and preventing scarring
  • Evidence supporting low-dose, extended-release minocycline for rosacea
  • The anti-inflammatory role of tetracyclines in rosacea treatment
  • Use of very low-dose isotretinoin in selected patients
  • Challenges and treatment considerations for neurogenic and ocular rosacea

Explore Related Resources

MORE 2026 AAD INNOVATION ACADEMY CONFERENCE COVERAGE:

Peter Lio, MD: Expanding Career Opportunities in Dermatology

Dr. Lio explores how dermatologists can extend their influence beyond traditional one-on-one patient care through entrepreneurial, advisory, and professional opportunities across the healthcare industry. He

Tina Bhutani, MD, MAS: Inflammatory Skin Disorders in Skin of Color

Dr. Bhutani discusses the unique presentation of inflammatory skin diseases in patients with skin of color, highlighting important diagnostic and treatment considerations for Psoriasis, Atopic

Paradi Mirmirani, MD: Hair Loss During Menopause

Dr. Mirmirani discusses hair loss during menopause, an often overlooked concern that can significantly affect women during the transition through midlife. She presents a 3-pillar

Christopher Bunick, MD, PhD: The Future of Small Molecule Drugs in Dermatology

Dr. Bunick explores the scientific principles guiding the next generation of small molecule therapies in dermatology. He outlines how intentional drug design can improve efficacy,

Nada Elbuluk, MD: Pearls for Pigmentary Disorders in Skin of Color

Dr. Elbuluk reviews practical strategies for evaluating and treating hyperpigmentation, hypopigmentation, and depigmentation in patients with skin of color. She emphasizes that accurate diagnosis and

Diego Ruiz Dasilva, MD: Challenging the Status Quo of Lab Monitoring in Dermatology

Dr. Dasilva examines longstanding laboratory monitoring practices in dermatology and encourages clinicians to reconsider routine testing as new evidence emerges. He reviews monitoring recommendations for

Steven Daveluy, MD: Laughter Yoga for Stress and Wellbeing

Dr. Daveluy discusses laughter yoga, a practice based on the idea that intentional laughter can produce many of the same physiological and psychological responses as

Amy McMichael, MD: Building a Successful Dermatology Department

Dr. McMichael shares practical leadership insights for building and sustaining a successful dermatology department. She emphasizes creating a strong departmental culture in which every team

Jennifer Hsiao, MD: Off-Label Approaches for Recalcitrant Hidradenitis Suppurativa

Dr. Hsiao reviews practical off-label strategies for patients with recalcitrant hidradenitis suppurativa whose disease remains active despite standard treatment. She emphasizes individualized, multimodal care that